Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s15010-020-01473-w http://scihub22266oqcxt.onion/10.1007/s15010-020-01473-w 32725595!7386384!32725595     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Infection 2020 ; 48 (6): 861-870 Nephropedia Template TP {{tp|p=32725595|t=2020. Cardiac manifestations of COVID-19 in Shenzhen, China |pdf=|usr=}}{{32725595}} gab.com Text Cardiac manifestations of COVID-19 in Shenzhen, China JO: Infection http://www.kidney.de/pget.php?&tw=1&pmid=32725595 #FOAvip PURPOSE: The coronavirus disease 2019 (COVID-19) outbreak has become a global public health concern; however, relatively few detailed reports of related cardiac injury are available. The aims of this study were to compare the clinical and echocardiographic characteristics of inpatients in the intensive-care unit (ICU) and non-ICU patients. METHODS: We recruited 416 patients diagnosed with COVID-19 and divided them into two groups: ICU (n = 35) and non-ICU (n = 381). Medical histories, laboratory findings, and echocardiography data were compared. RESULTS: The levels of myocardial injury markers in ICU vs non-ICU patients were as follows: troponin I (0.029 ng/mL [0.007-0.063] vs 0.006 ng/mL [0.006-0.006]) and myoglobin (65.45 mug/L [39.77-130.57] vs 37.00 mug/L [26.40-53.54]). Echocardiographic findings included ventricular wall thickening (12 [39%] vs 1 [4%]), pulmonary hypertension (9 [29%] vs 0 [0%]), and reduced left-ventricular ejection fraction (5 [16%] vs 0 [0%]). Overall, 10% of the ICU patients presented with right heart enlargement, thickened right-ventricular wall, decreased right heart function, and pericardial effusion. Cardiac complications were more common in ICU patients, including acute cardiac injury (21 [60%] vs 13 [3%]) (including 2 cases of fulminant myocarditis), atrial or ventricular tachyarrhythmia (3 [9%] vs 3 [1%]), and acute heart failure (5 [14%] vs 0 [0%]). CONCLUSION: Myocardial injury marker elevation, ventricular wall thickening, pulmonary artery hypertension, and cardiac complications including acute myocardial injury, arrhythmia, and acute heart failure are more common in ICU patients with COVID-19. Cardiac injury in COVID-19 patients may be related more to the systemic response after infection rather than direct damage by coronavirus. Twit Text FOAVip Cardiac manifestations of COVID-19 in Shenzhen, China ????Infection http://www.kidney.de/pget.php?&tw=1&pmid=32725595 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32725595 #FOAvip English Wikipedia <ref>{{Cite pmid|32725595}}</ref> Cardiac manifestations of COVID-19 in Shenzhen, China #MMPMID32725595 Zeng JH; Wu WB; Qu JX; Wang Y; Dong CF; Luo YF; Zhou D; Feng WX; Feng C Infection 2020[Dec]; 48 (6): 861-870 PMID32725595show ga PURPOSE: The coronavirus disease 2019 (COVID-19) outbreak has become a global public health concern; however, relatively few detailed reports of related cardiac injury are available. The aims of this study were to compare the clinical and echocardiographic characteristics of inpatients in the intensive-care unit (ICU) and non-ICU patients. METHODS: We recruited 416 patients diagnosed with COVID-19 and divided them into two groups: ICU (n = 35) and non-ICU (n = 381). Medical histories, laboratory findings, and echocardiography data were compared. RESULTS: The levels of myocardial injury markers in ICU vs non-ICU patients were as follows: troponin I (0.029 ng/mL [0.007-0.063] vs 0.006 ng/mL [0.006-0.006]) and myoglobin (65.45 mug/L [39.77-130.57] vs 37.00 mug/L [26.40-53.54]). Echocardiographic findings included ventricular wall thickening (12 [39%] vs 1 [4%]), pulmonary hypertension (9 [29%] vs 0 [0%]), and reduced left-ventricular ejection fraction (5 [16%] vs 0 [0%]). Overall, 10% of the ICU patients presented with right heart enlargement, thickened right-ventricular wall, decreased right heart function, and pericardial effusion. Cardiac complications were more common in ICU patients, including acute cardiac injury (21 [60%] vs 13 [3%]) (including 2 cases of fulminant myocarditis), atrial or ventricular tachyarrhythmia (3 [9%] vs 3 [1%]), and acute heart failure (5 [14%] vs 0 [0%]). CONCLUSION: Myocardial injury marker elevation, ventricular wall thickening, pulmonary artery hypertension, and cardiac complications including acute myocardial injury, arrhythmia, and acute heart failure are more common in ICU patients with COVID-19. Cardiac injury in COVID-19 patients may be related more to the systemic response after infection rather than direct damage by coronavirus. |*SARS-CoV-2[MESH] |Aged[MESH] |COVID-19/*complications/diagnosis/*epidemiology/virology[MESH] |China/epidemiology[MESH] |Comorbidity[MESH] |Critical Care[MESH] |Echocardiography[MESH] |Female[MESH] |Heart Diseases/diagnosis/*epidemiology/*etiology/mortality[MESH] |Heart Function Tests[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Myocarditis/diagnosis/epidemiology/etiology[MESH] |Prognosis[MESH] |Radiography, Thoracic[MESH]Cardiac manifestations of COVID-19 in Shenzhen, China (epmc).pdf DeepDyve Pubget Overpricing